Cargando…

Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia

PURPOSE: To examine associations between the APOE-ε2 and APOE-ε4 alleles and core Alzheimer’s disease (AD) pathological hallmarks as measured by amyloid-β (Aβ) and tau PET in older individuals without dementia. METHODS: We analyzed data from 462 ADNI participants without dementia who underwent Aβ ([...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvadó, Gemma, Grothe, Michel J., Groot, Colin, Moscoso, Alexis, Schöll, Michael, Gispert, Juan Domingo, Ossenkoppele, Rik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175302/
https://www.ncbi.nlm.nih.gov/pubmed/33521872
http://dx.doi.org/10.1007/s00259-021-05192-8
_version_ 1783703025931517952
author Salvadó, Gemma
Grothe, Michel J.
Groot, Colin
Moscoso, Alexis
Schöll, Michael
Gispert, Juan Domingo
Ossenkoppele, Rik
author_facet Salvadó, Gemma
Grothe, Michel J.
Groot, Colin
Moscoso, Alexis
Schöll, Michael
Gispert, Juan Domingo
Ossenkoppele, Rik
author_sort Salvadó, Gemma
collection PubMed
description PURPOSE: To examine associations between the APOE-ε2 and APOE-ε4 alleles and core Alzheimer’s disease (AD) pathological hallmarks as measured by amyloid-β (Aβ) and tau PET in older individuals without dementia. METHODS: We analyzed data from 462 ADNI participants without dementia who underwent Aβ ([(18)F]florbetapir or [(18)F]florbetaben) and tau ([(18)F]flortaucipir) PET, structural MRI, and cognitive testing. Employing APOE-ε3 homozygotes as the reference group, associations between APOE-ε2 and APOE-ε4 carriership with global Aβ PET and regional tau PET measures (entorhinal cortex (ERC), inferior temporal cortex, and Braak-V/VI neocortical composite regions) were investigated using linear regression models. In a subset of 156 participants, we also investigated associations between APOE genotype and regional tau accumulation over time using linear mixed models. Finally, we assessed whether Aβ mediated the cross-sectional and longitudinal associations between APOE genotype and tau. RESULTS: Compared to APOE-ε3 homozygotes, APOE-ε2 carriers had lower global Aβ burden (β(std) [95% confidence interval (CI)]: − 0.31 [− 0.45, − 0.16], p = 0.034) but did not differ on regional tau burden or tau accumulation over time. APOE-ε4 participants showed higher Aβ (β(std) [95%CI]: 0.64 [0.42, 0.82], p < 0.001) and tau burden (β(std) range: 0.27-0.51, all p < 0.006). In mediation analyses, APOE-ε4 only retained an Aβ-independent effect on tau in the ERC. APOE-ε4 showed a trend towards increased tau accumulation over time in Braak-V/VI compared to APOE-ε3 homozygotes (β(std) [95%CI]: 0.10 [− 0.02, 0.18], p = 0.11), and this association was fully mediated by baseline Aβ. CONCLUSION: Our data suggest that the established protective effect of the APOE-ε2 allele against developing clinical AD is primarily linked to resistance against Aβ deposition rather than tau pathology. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-021-05192-8.
format Online
Article
Text
id pubmed-8175302
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81753022021-06-17 Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia Salvadó, Gemma Grothe, Michel J. Groot, Colin Moscoso, Alexis Schöll, Michael Gispert, Juan Domingo Ossenkoppele, Rik Eur J Nucl Med Mol Imaging Original Article PURPOSE: To examine associations between the APOE-ε2 and APOE-ε4 alleles and core Alzheimer’s disease (AD) pathological hallmarks as measured by amyloid-β (Aβ) and tau PET in older individuals without dementia. METHODS: We analyzed data from 462 ADNI participants without dementia who underwent Aβ ([(18)F]florbetapir or [(18)F]florbetaben) and tau ([(18)F]flortaucipir) PET, structural MRI, and cognitive testing. Employing APOE-ε3 homozygotes as the reference group, associations between APOE-ε2 and APOE-ε4 carriership with global Aβ PET and regional tau PET measures (entorhinal cortex (ERC), inferior temporal cortex, and Braak-V/VI neocortical composite regions) were investigated using linear regression models. In a subset of 156 participants, we also investigated associations between APOE genotype and regional tau accumulation over time using linear mixed models. Finally, we assessed whether Aβ mediated the cross-sectional and longitudinal associations between APOE genotype and tau. RESULTS: Compared to APOE-ε3 homozygotes, APOE-ε2 carriers had lower global Aβ burden (β(std) [95% confidence interval (CI)]: − 0.31 [− 0.45, − 0.16], p = 0.034) but did not differ on regional tau burden or tau accumulation over time. APOE-ε4 participants showed higher Aβ (β(std) [95%CI]: 0.64 [0.42, 0.82], p < 0.001) and tau burden (β(std) range: 0.27-0.51, all p < 0.006). In mediation analyses, APOE-ε4 only retained an Aβ-independent effect on tau in the ERC. APOE-ε4 showed a trend towards increased tau accumulation over time in Braak-V/VI compared to APOE-ε3 homozygotes (β(std) [95%CI]: 0.10 [− 0.02, 0.18], p = 0.11), and this association was fully mediated by baseline Aβ. CONCLUSION: Our data suggest that the established protective effect of the APOE-ε2 allele against developing clinical AD is primarily linked to resistance against Aβ deposition rather than tau pathology. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-021-05192-8. Springer Berlin Heidelberg 2021-02-01 2021 /pmc/articles/PMC8175302/ /pubmed/33521872 http://dx.doi.org/10.1007/s00259-021-05192-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Salvadó, Gemma
Grothe, Michel J.
Groot, Colin
Moscoso, Alexis
Schöll, Michael
Gispert, Juan Domingo
Ossenkoppele, Rik
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
title Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
title_full Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
title_fullStr Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
title_full_unstemmed Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
title_short Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
title_sort differential associations of apoe-ε2 and apoe-ε4 alleles with pet-measured amyloid-β and tau deposition in older individuals without dementia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175302/
https://www.ncbi.nlm.nih.gov/pubmed/33521872
http://dx.doi.org/10.1007/s00259-021-05192-8
work_keys_str_mv AT salvadogemma differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia
AT grothemichelj differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia
AT grootcolin differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia
AT moscosoalexis differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia
AT schollmichael differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia
AT gispertjuandomingo differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia
AT ossenkoppelerik differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia
AT differentialassociationsofapoee2andapoee4alleleswithpetmeasuredamyloidbandtaudepositioninolderindividualswithoutdementia